Académique Documents
Professionnel Documents
Culture Documents
the risk of recurrence is quadrupled after two prior postterm pregnancies [ 13-15 ]. Additional,
more modest risk factors (RR <2) include [ 11,13,14,16-21 ]:
Nulliparity
Male fetus
Maternal obesity
MORBIDITY AND MORTALITY Postterm pregnancy is associated with fetal, neonatal, and
maternal risks [ 22-26 ].
Fetal and neonatal risks Postterm fetuses tend to be larger than term fetuses, with a higher
incidence of macrosomia (4500 g) (2.5 to 10 percent versus 0.8 to 1 percent at term) [ 27-29 ].
Complications of macrosomia include prolonged labor, cephalopelvic disproportion, and
shoulder dystocia, all of which increase the risk of birth injury. (See "Fetal macrosomia" and
"Timing and route of delivery in pregnancies at risk of shoulder dystocia" .)
In contrast, up to 20 percent of postterm fetuses have "fetal dysmaturity (postmaturity)
syndrome," a term used to describe infants with characteristics of chronic intrauterine
malnutrition [ 30-32 ]. These fetuses are at increased risk of umbilical cord compression due to
oligohydramnios, and nonreassuring antepartum or intrapartum fetal heart rate patterns due to
placental insufficiency or cord compression. Meconium passage is common and may be related
to physiological maturation of the gut or fetal hypoxia. Neonates have a long thin body, long
nails, and are small for gestational age. Their skin is dry (vernix caseosa is decreased or absent),
meconium stained, parchment-like, and peeling; it appears loose, especially over the thighs and
buttocks, and has prominent creases; lanugo hair is sparse or absent, while scalp hair is
increased. These fetuses/neonates are at risk for the short- and long-term morbidity typically seen
in intrauterine growth restriction/small for gestational age infants. (See "Postterm infant" and
"Fetal growth restriction: Evaluation and management", section on 'Outcome' and "Small for
gestational age infant" .)
Perinatal mortality increases as pregnancy extends beyond 39 to 40 weeks of gestation due to
increases in both non-anomalous stillbirths and early neonatal deaths [ 33-36 ]. Intrauterine
infection, placental insufficiency and cord compression leading to fetal hypoxia, asphyxia, and
meconium aspiration are thought to contribute to the excess perinatal deaths [ 37,38 ]. The
perinatal mortality rate at 42 weeks of gestation is twice the rate at term, increasing four-fold at
43 weeks, and five- to seven-fold at 44 weeks [ 25,38-41 ]. Neonates born at 41 weeks of
gestation experience one-third greater neonatal mortality than term neonates born at 38 to 40
weeks of gestation [ 33 ]. However, the absolute risk of fetal or neonatal death is low. (See
'Expectant management' below and "Postterm infant", section on 'Perinatal mortality' .)
The long-term effects of postterm birth are unclear. Studies on long-term outcomes for children
born postterm are reviewed separately. (See "Postterm infant", section on 'Long-term outcome' .)
Maternal risks Maternal risks of postterm pregnancy include an increased frequency of labor
abnormalities and sequelae of labor induction and fetal macrosomia. These sequelae include
failed induction, third and fourth degree perineal lacerations, and postpartum hemorrhage [ 42-44
].
MANAGEMENT The following discussion refers to the singleton, cephalic fetus of an
otherwise uncomplicated pregnancy that reaches 41 weeks of gestation. Multiple gestations, noncephalic presentations, and complicated pregnancies are generally delivered before 41 weeks.
We favor induction of well-dated postterm pregnancies at or shortly after 41 0/7ths weeks of
gestation, irrespective of cervical status. The alternative is expectant management with ongoing
fetal assessment with intervention if fetal assessment is not reassuring or spontaneous labor does
not occur by a predefined gestational age. Both of these approaches are associated with low
complication rates in the low-risk postterm gravida [ 45 ].
Induction Induction of postterm pregnancy rather than expectant management with fetal
monitoring is supported by several lines of evidence:
When fetal mortality is based on the number of fetal deaths per 1000 ongoing
pregnancies (rather than per 1000 deliveries), an analysis of fetal versus neonatal
mortality rates concluded the rate of fetal demise was significantly higher than the rate of
neonatal death at any gestational age 40 3/7ths weeks of gestation [ 47 ].
Meta-analyses have reported that routine induction at >41 weeks results in no increase in
the risk of cesarean delivery compared with expectant management (RR 0.91, 95% CI
0.82-1.00; 12 trials, 5994 patients) [ 46 ] or a decrease in the cesarean birth rate (pooled
cesarean delivery rate with induction at 41 weeks: 17.5 versus 20.1 percent; P = 0.04; 8
trials, 6054 women) [ 48 ].
Patient satisfaction
We agree with guidelines that suggest routine induction between 41 0/7ths and 42 0/7ths weeks of
gestation rather than expectant management and monitoring as intervention at this time reduces
perinatal mortality without increasing perinatal morbidity or cesarean delivery rates [ 8,50 ]. The
exact timing during this week should take into account clinician and patient preferences and local
circumstances. We favor induction of well-dated postterm pregnancies at or shortly after 41 0/7ths
weeks of gestation.
However, this approach has not been universally accepted [ 51 ], in part because of the low
absolute rates of fetal and neonatal death: at 41 0/7ths weeks, 527 inductions would be necessary to
prevent one perinatal death; at 43 weeks, 195 inductions would be necessary to prevent one
perinatal death [ 52 ].
We utilize cervical ripening agents in women with unfavorable cervices. In women wishing to
avoid pharmacologic agents for cervical ripening and induction, membrane sweeping (also called
stripping) can be performed if the cervix is sufficiently dilated, and reduces the proportion of
patients who remain undelivered at 42 weeks. This was illustrated in a trial that randomly
assigned 742 low-risk women at 41 weeks of gestation to membrane sweeping every 48 hours or
expectant management [ 53 ]. At baseline, the Bishop score was <6 in 78 percent of women in
the intervention group; the expectant management group did not undergo cervical examination.
Serial membrane sweeping resulted in fewer pregnancies reaching 42 0/7ths weeks (23 versus 41
percent without membrane sweeping, RR 0.57 95% CI 0.46-0.71, number needed to treat 6). The
optimum time to initiate membrane sweeping and the frequency (once versus on multiple days)
has not been studied. Beginning anytime after 39 weeks of gestation is reasonable. (See
"Techniques for ripening the unfavorable cervix prior to induction" .)
Expectant management Postterm pregnancy is a universally accepted indication for antenatal
fetal monitoring because the risk of antepartum fetal demise increases with advancing gestational
age. In large studies from the United Kingdom, the risk of antepartum fetal demise was [ 54 ]:
However, the efficacy of antenatal fetal assessment for preventing unexplained fetal demise in
postterm fetuses has not been validated by appropriately sized and placebo-controlled
randomized trials, and probably never will be evaluated in this way because of ethical and
medicolegal concerns of assigning some pregnancies to an unmonitored group. One small trial
that compared two methods of fetal assessment has been performed, and did not find a difference
in neonatal outcome between groups [ 55 ].
The optimal type and frequency of fetal testing, and the gestational age for beginning
monitoring, have not been determined. We suggest monitoring fetal well-being by the nonstress
testing with amniotic fluid volume assessment or by the biophysical profile (BPP); neither
method has been proven to be superior. Doppler ultrasonography of the umbilical artery has no
proven benefit in monitoring the postterm fetus and is not recommended for this indication [
56,57 ]. Case control studies support initiating antepartum fetal surveillance between 41 0/7ths and
42 0/7ths weeks of gestation (287 to 294 days) [ 58,59 ]. We suggest twice weekly testing beginning
at 41 0/7ths weeks or shortly thereafter. (See "Overview of fetal assessment", section on 'Antenatal
testing methods' .)
Induction is indicated for development of any of the usual obstetrical indications, including
evidence of oligohydramnios [ 60,61 ]. Adverse pregnancy outcomes (nonreassuring fetal heart
rate tracing, neonatal intensive care unit admission, low Apgar) are more likely when
oligohydramnios is present [ 60-65 ]. Frequent assessment is important because amniotic fluid
can become severely reduced within 24 to 48 hours [ 66 ]. (See "Oligohydramnios" .)